Investor Perspectives on Healthcare: Thomas Hawes of Blue Venture Fund

This is Investor Perspectives, I'm the host of Investor Connect, Hall T Martin, where we connect startups and investors for funding. In today's show, you'll hear about healthcare and its impact on startups. COVID-19 has changed the landscape for startups giving us a new normal. During the pandemic, it became clear the need for changes in our healthcare system. We have joining us, Thomas Hawes of Blue Venture Fund - an investor in the healthcare space. Tom is a member of the BlueCross BlueShield Fund Management team at Sandbox Industries and serves on the Sandbox Management Committee. He is the Board Chairman for Patientco, serves on the Board of Directors of Verata Health, Upward Health (fka BehaveCare), Octave Bioscience, Oncology Analytics, and AbleTo and is a board observer of HeartFlow, Thrive Earlier Detection, Phreesia, and Healthify. Tom holds a BA from Brigham Young University, an M.D. from New York Medical College, medical residency training at Yale, and an MBA from Harvard Business School. He is also a Kauffman Fellow. You can visit Blue Venture Fund at www.blueventurefund.com/. Thomas can be contacted via LinkedIn at www.linkedin.com/in/thomas-c-hawes-m-d-mba-b729522/, via Twitter at www.twitter.com/ThomasHawes, and via email at [email protected]. I hope you enjoy this episode.